Immediate Impact
35 standout
Citing Papers
2024 Standout
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Works of Sumul Raval being referenced
Cilengitide in patients with newly diagnosed glioblastoma multiforme and unmethylated MGMT gene promoter: Protocol of a multicenter, randomized, open-label, controlled phase II study.
2010
Bevacizumab and irinotecan in patients (pts) with recurrent glioblastoma multiforme (GBM)
2007
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sumul Raval | 24 | 9 | 10 | 3 | 29 | |
| Vachan Vadmal | 14 | 8 | 11 | 2 | 33 | |
| Jad Alshami | 19 | 11 | 8 | 4 | 29 | |
| Brooklyn Chaney | 22 | 6 | 5 | 2 | 24 | |
| F. Dhermain | 21 | 3 | 15 | 4 | 26 | |
| Ayman Taher | 10 | 6 | 4 | 2 | 21 | |
| Beatrice S. Melin | 13 | 2 | 5 | 2 | 21 | |
| Daifulah Al-Zahrani | 31 | 6 | 22 | 3 | 203 | |
| Alissa Greenwald | 7 | 17 | 5 | 2 | 46 | |
| Evelyne Guay | 11 | 2 | 8 | 4 | 19 | |
| Janice Cheng | 12 | 7 | 7 | 4 | 30 |
All Works
Loading papers...